Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biqi Capsule for Bone Protection in Rheumatoid Arthritis
ChiCTR-IPR-16009029Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Biqi Capsule in rheumatoid arthritis (RA) and osteoarthritis (OA) (4 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Modified Sharp-van der Heijde score, ACR20 response and 16 more. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
Biqi Capsule
03
Conditions
rheumatoid arthritis (RA)osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-16009029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009029.